Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors

Transfusion

Volumn 56, Issue 9, 2016, Pages 2225-2232

  Harritshøj, Lene H ^a   Holm, Dorte K ^b   Sækmose, Susanne G ^c   Jensen, Bitten A ^d   Hogema, Boris M ^e   Fischer, Thea K ^f   Midgley, Sofie E ^f   Krog, Jesper S ^g   Erikstrup, Christian ^h   Ullum, Henrik ^a  

^a Rigshospitalet   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c NAESTVED HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e SANQUIN RESEARCH   (Netherlands)

^f STATENS SERUM INSTITUT   (Denmark)

^g TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; DANISH CITIZEN; DENMARK; EUROPE; FEMALE; FOLLOW UP; GENE SEQUENCE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 3; HUMAN; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTICS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID AMPLIFICATION TEST; NUCLEIC ACID ANALYSIS; PHYLOGENETIC TREE; PHYLOGENY; PIG; POSTTRANSFUSION HEPATITIS; PREVALENCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; RETROSPECTIVE STUDY; SCREENING; SECONDARY IMMUNE RESPONSE; VERY ELDERLY; VIRUS LOAD; YOUNG ADULT;

EID: 84987642125     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13700     Document Type: Article

References (34)

1. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012;367:1237–44.
2. Dalton HR, Pas SD, Madden RG, van der Eijk AA. Hepatitis E virus: current concepts and future perspectives [serial online]. Curr Infect Dis Rep 2014;16:399.
3. Van der Poel WH. Food and environmental routes of hepatitis E virus transmission. Curr Opin Virol 2014;4:91–6.
4. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012;379:2477–88.
5. Berto A, Backer JA, Mesquita JR, et al. Prevalence and transmission of hepatitis E virus in domestic swine populations in different European countries [serial online]. BMC Res Notes 2012;5:190
6. Breum SO, Hjulsager CK, de Deus N, Segales J, Larsen LE. Hepatitis E virus is highly prevalent in the Danish pig population. Vet Microbiol 2010;146(1-2):144–9.
7. Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008;20:784–90.
8. Holm DK, Moessner BK, Engle RE, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 2015;55:1662–7.
9. Vollmer T, Diekmann J, Johne R, Eberhardt M, Knabbe C, Dreier J. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012;50:2708–13.
10. Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012;103:89–90.
11. Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M, Zaaijer HL. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012 [serial online]. Euro Surveill 2013;18. pii: 20550.
12. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384:1766–73.
13. Fischer C, Hofmann M, Danzer M, Hofer K, Kaar J, Gabriel C. Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria [serial online]. PLoS One 2015;10:e0119576.
14. Stramer SL, Moritz ED, Foster GA, et al. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion 2016;56:481–8.
15. Hogema BM, Molier M, Sjerps M, et al. Incidence and duration of hepatitis E virus infection in Dutch blood donors. Transfusion 2016;56:722–8.
16. Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a “nonhyperendemic” country. Transfus Med 2006;16:79–83.
17. Colson P, Coze C, Gallian P, Henfy M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007;13:648–9.
18. Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008;48:1368–75.
19. Fuse K, Matsuyama Y, Moriyama M, et al. Late onset post-transfusion hepatitis E developing during chemotherapy for acute promyelocytic leukemia. Intern Med 2015;54:657–61.
20. Sauleda S, Ong E, Bes M, et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015;55:972–9.
21. Midgley S, Vestergaard HT, Dalgaard C, Enggaard L, Fischer TK. Hepatitis E virus genotype 4, Denmark, 2012. Emerg Infect Dis 2014;20:156–7.
22. Smith DB, Ijaz S, Tedder RS, et al. Variability and pathogenicity of hepatitis E virus genotype 3 variants. J Gen Virol 2015;96:3255–64.
23. VassarStats. VassarStats: Website for Statistical Computation. 2016 [cited 2016 Mar 1].http://vassarstats.net/index.html.
24. Beale MA, Tettmar K, Szypulska R, Tedder RS, Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011;100:340–2.
25. Juhl D, Baylis SA, Blumel J, Gorg S, Hennig H. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion 2014;54:49–56.
26. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799–805.
27. Teshale EH, Denniston MM, Drobeniuc J, Kamili S, Teo CG, Holmberg SD. Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010. J Infect Dis 2015;1;211:366–73.
28. Hogema BM, Molier M, Slot E, Zaaijer HL. Past and present of hepatitis E in the Netherlands. Transfusion 2014;54:3092–6.
29. Chaussade H, Rigaud E, Allix A, et al. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol 2013;58:504–8.
30. Ijaz S, Said B, Boxall E, Smit E, Morgan D, Tedder RS. Indigenous hepatitis E in England and Wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses. J Infect Dis 2014;209:1212–8.
31. Smith DB, Simmonds P, Jameel S, et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol 2015;96(pt 5):1191–2.
32. Mansuy JM, Saune K, Rech H, et al. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France. Euro Surveill 2015;20:27–34.
33. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003;362:371–3.
34. Mansuy JM, Abravanel F, Miedouge M, et al. Acute hepatitis E in south-west France over a 5-year period. J Clin Virol 2009;44:74–7.